{"id":943593,"date":"2026-03-11T09:38:10","date_gmt":"2026-03-11T13:38:10","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-to-present-at-lsi-usa-26\/"},"modified":"2026-03-11T09:38:10","modified_gmt":"2026-03-11T13:38:10","slug":"autonomix-medical-to-present-at-lsi-usa-26","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-to-present-at-lsi-usa-26\/","title":{"rendered":"Autonomix Medical to Present at LSI USA \u201926"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">\n        <b>THE WOODLANDS, TX, March  11, 2026  (GLOBE NEWSWIRE) &#8212; <\/b><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1nXArqvCzoVpW0bWzQBSJocclvCqK0KThC3VQUPaB5W2Cgz8uIL_xFHVZIUrKvrr17gDeZuapInBcPgaorNDgpb_rXsMQYzxmQ973c53ZTzD2x6eg7qe9edBRjwm1NeX23cTd4vmqxeveJwm4pxm5zK9mmHWsvDatKDeIfLZ7C8Zt9GhWRTrZXrUrDEoE-3YBSeZkbtjHE-xZHyfSynYLHBaB5DqikI6YbgXaKC670cSM_YMocRQJ0gF4aaEdODc8PsehW652WVlOiswa8UMFA==\" rel=\"nofollow\" target=\"_blank\">Autonomix Medical, Inc.<\/a>\u00a0(NASDAQ: AMIX) (\u201cAutonomix\u201d or the \u201cCompany\u201d), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced that <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_DiSrBg5zTi3IqPZXbuZrfYK0UN2HnU8LNjrIPql9KCOQMr6pgLuGLndc8rwZvQz3xCiacdQUSygpELJovmc9enxI9lsxubLAGo69_uwMSrPTxWOHSMa_QAto5JtITchCQ9eXI9XvluYZkZB_gpmfiLPGI_i4FVza3FDaBh71dE=\" rel=\"nofollow\" target=\"_blank\">Brad Hauser, President and Chief Executive Officer<\/a> of Autonomix will present at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=SQGm2jX-YKCbWWlFCskKSx7GQcF7CRvmmc7Oej1JP6r7e7cTTTH4mdLeUsnEy6Z_SMyjP-1bozz1GZTA-8BUr1GwBsemqpuNKoxErVqLDi1M3tS_K3R8G9yrrBjArvEKa-WfpWOImgCaCpg2yYKBqUCVaHjyFVIWcgyJlSuLwsUVrrREpKuNWMAspGm2oNkrtXIS4kb2qgXA-6JmALInXgKGL4FF03xrnXsHvy_dbns=\" rel=\"nofollow\" target=\"_blank\">LSI USA \u201926<\/a> on Tuesday, March 17, 2026 at 9:15 AM PT.<\/p>\n<p align=\"justify\">In addition to the presentation, management will be available to participate in in-person one-on-one meetings with qualified members of the investor community who are registered to attend the conference.<\/p>\n<p align=\"justify\">The in-person presentation will be accessible to those registered to attend the event. For more information, please visit the\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3bQ95ifpauvIaXh4blllpFcfr-FCIr8ZHJs88pZyfBE4AJHKs1Nw78Nj1fLGRtXaWzQqSnfNwRYU0o3_B4-jyBExUma2-4UQafkSirreo5uWxMSn5lIbNBRKBQW2WzH-4euvKejQlZtOUG-uWAUeYxm-CN4i5fJ7-XytSQdoAq1tsndT7_PAIRqDqCke-LpRfTkBhQcVLi_2f75XdWy_2P6HBwfriXFahCYuK--IPpAUMWMvai33CQ7SLGohNFVN\" rel=\"nofollow\" target=\"_blank\">conference website<\/a>.<\/p>\n<p align=\"justify\">LSI USA &#8217;26, organized by Life Science Intelligence, is a leading global medtech summit that convenes executives, investors and innovators from across the healthcare industry. The event features keynote sessions, expert panels and startup presentations focused on advancing medical technology, fostering partnerships and accelerating innovation across the life sciences sector.<\/p>\n<p align=\"justify\">\n        <b>About Autonomix Medical, Inc.<\/b>\n      <\/p>\n<p align=\"justify\">Autonomix is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated. The Company\u2019s first-in-class platform system technology includes a catheter-based microchip sensing array that may have the ability to detect and differentiate neural signals with greater sensitivity than currently available technologies. We believe this will enable, for the first time ever, transvascular diagnosis and treatment of diseases involving the peripheral nervous system virtually anywhere in the body.<\/p>\n<p align=\"justify\">We are initially developing this technology for the treatment of pain, with initial trials focused on pancreatic cancer, a condition that causes debilitating pain and is without a reliable solution. Our technology constitutes a platform to address dozens of potential indications, including cardiology, hypertension and chronic pain management, across a wide disease spectrum. Our technology is investigational and has not yet been cleared for marketing in the United States.<\/p>\n<p>For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=p8zPkl3uVDpUlC6wZ_rHDj4lFqR3CqqCuaL5oQb281VLxqSK_YKH7AFHHykP3pGK0fnvuIIlwMN2KyGWReOfLw==\" rel=\"nofollow\" target=\"_blank\">autonomix.com<\/a> and connect with the Company on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=KofgEl_LqUa1TemSpQAre2T9zoFYlNXomoUvLFc7AAvoVS2JYNt1j9KXAKemjt_9WG7U1RnMxO_W_mHQd0wHTA==\" rel=\"nofollow\" target=\"_blank\">X<\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=IozhuhWK_YWXp8BMMj0iSWCgaFCvEre9EgQYiiu3vWX0MOEPs9999kV8JuKCNrFu0qpRIIykpMEIcSih931ZJYBsjOpymN6IAGyLuPjNpsLl7zSDl8IXOhZ_my7nMlvQ\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=FyoRMluPTArHqxWjwERO3R1beXga5jlxERkXUb2SUDGZNVzVdHjimMXyIEhksmu6kipz2a01zkvuSR1ojdceNi7D1pvJPuKVgJOMmsrK-Gc=\" rel=\"nofollow\" target=\"_blank\">Instagram<\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nohMs4QAqpq0EFuM0wWZ9L07VWNU7-lwgDj3ZPmWGkrQgs19G3744get4mblGcdJ8y3mHTa2IFaZ08gG-RFy4flAtpqnYg3THCsNKSFwSMGdI12U0trJQqMrAehDzsFC\" rel=\"nofollow\" target=\"_blank\">Facebook<\/a>. <\/p>\n<p><b>Forward Looking Statements<\/b><\/p>\n<p align=\"justify\">Some of the statements in this release are \u201cforward-looking statements,\u201d which involve risks and uncertainties. Such forward-looking statements can be identified by the use of words such as \u201cshould,\u201d \u201cmight,\u201d \u201cmay,\u201d \u201cintends,\u201d \u201canticipates,\u201d \u201cbelieves,\u201d \u201cestimates,\u201d \u201cprojects,\u201d \u201cforecasts,\u201d \u201cexpects,\u201d \u201cplans,\u201d and \u201cproposes.\u201d Forward-looking statements in this press release include expectations regarding the potential effectiveness and clinical benefits of Autonomix&#8217;s nerve-targeted treatments for pancreatic cancer pain and other conditions.<\/p>\n<p align=\"justify\">Although Autonomix believes that the expectations reflected in these forward-looking statements are based on reasonable assumptions, there are a number of risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading \u201cRisk Factors\u201d and elsewhere in the Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (SEC) on May 29, 2025, and from time to time, our other filings with the SEC. Forward-looking statements speak only as of the date of this press release and Autonomix does not undertake any duty to update any forward-looking statements except as may be required by law.<\/p>\n<p>\n        <b>Investor and Media Contact<\/b><br \/>\n        <br \/>JTC Team, LLC<br \/>Jenene Thomas<br \/>908.824.0775<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=p8zPkl3uVDpUlC6wZ_rHDuh4kgtnQOfKf2w1xIgQHx73hW4NzaUu-TpI0sKKLSVWJLA83QtWaASYraXvKFKUeJnRFSTR7KXZa5iQ437D8Vk=\" rel=\"nofollow\" target=\"_blank\">autonomix@jtcir.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2OTY5NyM3NDc4ODIzIzUwMDExOTk5Mg==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MWNiOTEyNzEtNzQwOC00NzA0LWFiNmMtNjA1YzA0OWYzYzczLTUwMDExOTk5Mi0yMDI2LTAzLTExLWVu\/tiny\/Autonomix-Medical-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>THE WOODLANDS, TX, March 11, 2026 (GLOBE NEWSWIRE) &#8212; Autonomix Medical, Inc.\u00a0(NASDAQ: AMIX) (\u201cAutonomix\u201d or the \u201cCompany\u201d), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced that Brad Hauser, President and Chief Executive Officer of Autonomix will present at LSI USA \u201926 on Tuesday, March 17, 2026 at 9:15 AM PT. In addition to the presentation, management will be available to participate in in-person one-on-one meetings with qualified members of the investor community who are registered to attend the conference. The in-person presentation will be accessible to those registered to attend the event. For more information, please visit the\u00a0conference website. LSI USA &#8217;26, organized by Life Science Intelligence, is a leading global medtech summit that convenes executives, &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-to-present-at-lsi-usa-26\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Autonomix Medical to Present at LSI USA \u201926&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-943593","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Autonomix Medical to Present at LSI USA \u201926 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-to-present-at-lsi-usa-26\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Autonomix Medical to Present at LSI USA \u201926 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"THE WOODLANDS, TX, March 11, 2026 (GLOBE NEWSWIRE) &#8212; Autonomix Medical, Inc.\u00a0(NASDAQ: AMIX) (\u201cAutonomix\u201d or the \u201cCompany\u201d), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced that Brad Hauser, President and Chief Executive Officer of Autonomix will present at LSI USA \u201926 on Tuesday, March 17, 2026 at 9:15 AM PT. In addition to the presentation, management will be available to participate in in-person one-on-one meetings with qualified members of the investor community who are registered to attend the conference. The in-person presentation will be accessible to those registered to attend the event. For more information, please visit the\u00a0conference website. LSI USA &#8217;26, organized by Life Science Intelligence, is a leading global medtech summit that convenes executives, &hellip; Continue reading &quot;Autonomix Medical to Present at LSI USA \u201926&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-to-present-at-lsi-usa-26\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-11T13:38:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2OTY5NyM3NDc4ODIzIzUwMDExOTk5Mg==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-to-present-at-lsi-usa-26\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-to-present-at-lsi-usa-26\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Autonomix Medical to Present at LSI USA \u201926\",\"datePublished\":\"2026-03-11T13:38:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-to-present-at-lsi-usa-26\\\/\"},\"wordCount\":529,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-to-present-at-lsi-usa-26\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY2OTY5NyM3NDc4ODIzIzUwMDExOTk5Mg==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-to-present-at-lsi-usa-26\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-to-present-at-lsi-usa-26\\\/\",\"name\":\"Autonomix Medical to Present at LSI USA \u201926 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-to-present-at-lsi-usa-26\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-to-present-at-lsi-usa-26\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY2OTY5NyM3NDc4ODIzIzUwMDExOTk5Mg==\",\"datePublished\":\"2026-03-11T13:38:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-to-present-at-lsi-usa-26\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-to-present-at-lsi-usa-26\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-to-present-at-lsi-usa-26\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY2OTY5NyM3NDc4ODIzIzUwMDExOTk5Mg==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY2OTY5NyM3NDc4ODIzIzUwMDExOTk5Mg==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-to-present-at-lsi-usa-26\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Autonomix Medical to Present at LSI USA \u201926\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Autonomix Medical to Present at LSI USA \u201926 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-to-present-at-lsi-usa-26\/","og_locale":"en_US","og_type":"article","og_title":"Autonomix Medical to Present at LSI USA \u201926 - Market Newsdesk","og_description":"THE WOODLANDS, TX, March 11, 2026 (GLOBE NEWSWIRE) &#8212; Autonomix Medical, Inc.\u00a0(NASDAQ: AMIX) (\u201cAutonomix\u201d or the \u201cCompany\u201d), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced that Brad Hauser, President and Chief Executive Officer of Autonomix will present at LSI USA \u201926 on Tuesday, March 17, 2026 at 9:15 AM PT. In addition to the presentation, management will be available to participate in in-person one-on-one meetings with qualified members of the investor community who are registered to attend the conference. The in-person presentation will be accessible to those registered to attend the event. For more information, please visit the\u00a0conference website. LSI USA &#8217;26, organized by Life Science Intelligence, is a leading global medtech summit that convenes executives, &hellip; Continue reading \"Autonomix Medical to Present at LSI USA \u201926\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-to-present-at-lsi-usa-26\/","og_site_name":"Market Newsdesk","article_published_time":"2026-03-11T13:38:10+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2OTY5NyM3NDc4ODIzIzUwMDExOTk5Mg==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-to-present-at-lsi-usa-26\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-to-present-at-lsi-usa-26\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Autonomix Medical to Present at LSI USA \u201926","datePublished":"2026-03-11T13:38:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-to-present-at-lsi-usa-26\/"},"wordCount":529,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-to-present-at-lsi-usa-26\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2OTY5NyM3NDc4ODIzIzUwMDExOTk5Mg==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-to-present-at-lsi-usa-26\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-to-present-at-lsi-usa-26\/","name":"Autonomix Medical to Present at LSI USA \u201926 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-to-present-at-lsi-usa-26\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-to-present-at-lsi-usa-26\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2OTY5NyM3NDc4ODIzIzUwMDExOTk5Mg==","datePublished":"2026-03-11T13:38:10+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-to-present-at-lsi-usa-26\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-to-present-at-lsi-usa-26\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-to-present-at-lsi-usa-26\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2OTY5NyM3NDc4ODIzIzUwMDExOTk5Mg==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2OTY5NyM3NDc4ODIzIzUwMDExOTk5Mg=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-to-present-at-lsi-usa-26\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Autonomix Medical to Present at LSI USA \u201926"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/943593","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=943593"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/943593\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=943593"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=943593"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=943593"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}